Approval of the Resolution Plan by Hon''ble National Company Law Tribunal ("NCLT") of Cian Healthcare Limited. Further please find attached herewith the Specific features and details of ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The National Company Law Tribunal (NCLT), Mumbai Bench has approved the Resolution Plan submitted by Mr. Pradeep Kumar Jain (Successful Resolution Applicant) on December 18, 2025. Mr. Pradeep Kumar Jain was declared the SRA after securing 100% vote from the Committee of Creditors on May 9, 2025. Under the approved plan, the SRA will infuse ₹37.30 crores into the company, primarily to settle secured financial creditors (₹32.67 crores), CIRP costs, and operational/employee dues. The company's existing shareholding will be restructured — current promoter shares will be fully extinguished, and public shareholding will be reduced to just 5% of the new capital, with the incoming promoters taking 95% control. The company will continue to remain listed on BSE and operate as a going concern in the pharmaceutical sector.
Existing shareholders will face significant dilution/erosion — promoters lose their entire stake and public shareholders are reduced to a 5% minority with no direct compensation, while new promoters led by Ananta Medicare gain 95% control. The ₹37.30 crore infusion and debt restructuring provide a fresh start, but the drastic capital reduction signals near-total loss of value for current equity holders.